Items where authors include "Kunadian, V."

Article

Kunadian, V. orcid.org/0000-0003-2975-6971, Mossop, H., Shields, C. et al. (33 more authors) (2024) Invasive treatment strategy for older patients with myocardial infarction. New England Journal of Medicine, 391 (18). pp. 1673-1684. ISSN 0028-4793

Nadarajah, R. orcid.org/0000-0001-9895-9356, Ludman, P., Laroche, C. et al. (11 more authors) (2024) Presentation, care, coronary intervention and outcomes of patients with NSTEMI according to age: insights from the international prospective ACVC-EAPCI EORP NSTEMI registry. Age and Ageing, 53 (8). afae179. ISSN 0002-0729

Batra, G., Renlund, H., Kunadian, V. et al. (9 more authors) (2022) Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome : results from the PLATelet inhibition and patients Outcomes (PLATO) trial. European Heart Journal. Acute Cardiovascular Care, 11 (4). pp. 336-349. ISSN 2048-8726

Storey, R.F. orcid.org/0000-0002-6677-6229, Gurbel, P.A., ten Berg, J. et al. (14 more authors) (2020) Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromes. European Heart Journal, 41 (33). pp. 3132-3140. ISSN 0195-668X

Proceedings Paper

Storey, R.F. orcid.org/0000-0002-6677-6229, Gurbel, P.A., James, S. et al. (12 more authors) (2019) 2349: Selatogrel, a novel P2Y12 inhibitor for emergency use, achieves rapid, consistent and sustained platelet inhibition following single-dose subcutaneous administration in stable CAD patients. In: EUROPEAN HEART JOURNAL. ESC Congress 2019 together with World Congress of Cardiology, 31 Aug - 04 Sep 2019, Paris, France. Oxford University Press , p. 1355.